6:35am ET
Investing
20 Dividend Stocks for All Baby Boomers to Retire On
Here are 20 companies that should offer investors who are retired or near retirement some added income to help make their golden years safe and sound.
Companies
/Healthcare
Abbvie Inc
$263.80
▼ $0.22 (−0.08%) today
Markets open · 12:45pm ET
ABBV Coverage
Page 21
10:05am ET
Health and Healthcare
Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?
Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected to close in early 2020, but it is still subject to customary…
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:10am ET
Investing
6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential
The week of September 28 saw many analyst upgrades and positive calls in blue-chip stocks. Here are six that received very favorable analyst coverage with above-consensus upside projections.
10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and Whirlpool.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More
The top analyst upgrades, downgrades and initiations for Thursday included AbbVie, Ally Financial, Anthem, Caterpillar, CVS Health, Deere, Oracle, PayPal, Rite Aid, Square, Uber Technologies and UnitedHealth.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More
The top analyst upgrades, downgrades and initiations for Wednesday included AbbVie, Camping World, Cleveland-Cliffs, Coupa Software, Dollar General, DuPont, Nike, Roku and StoneCo.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
7:40am ET
Investing
5 Incredible Blue Chip Stocks With 6% or Higher Dividends
These five companies all pay at least a 6% dividend and offer a reasonable degree of safety. Even if a recovery in their share prices takes a while, the high dividends will…
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More
The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
8:40am ET
Health and Healthcare
Major Pharma Sees Rising Tide in Short Interest
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.